Novartis Investigative Site

Dayton, Ohio 45402

Use our guide to learn which trials are right for you!

We've found
5 trials
at this facility
Ankylosing Spondylitis Clinical Trial
Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling, Phase
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
Status: Enrolling, Phase II
Updated: 9/29/2014
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Relapsing Multiple Sclerosis Clinical Trial
A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg Fingolimod
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Influenza Clinical Trial
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)
Status: Upcoming, Phase III
Updated: 1/15/2016
Novartis Investigative Site
mi
from
Dayton, OH
Click here to add this to my saved trials